Teva Pharmaceutical Industries Limited
TEVA
NYSE
12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 3.23B | 2.25B | 2.67B | 2.14B | 2.80B |
Total Receivables | 3.41B | 3.39B | 3.54B | 3.44B | 3.70B |
Inventory | 4.02B | 4.05B | 4.11B | 4.12B | 3.83B |
Prepaid Expenses | 1.26B | 1.17B | 1.23B | 1.25B | 1.16B |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | 575.00M | 572.00M | 543.00M | 552.00M | 559.00M |
Total Current Assets | 12.49B | 11.43B | 12.09B | 11.50B | 12.05B |
|
|||||
Total Current Assets | 12.49B | 11.43B | 12.09B | 11.50B | 12.05B |
Net Property, Plant & Equipment | 6.15B | 6.03B | 6.13B | 6.17B | 6.16B |
Long-term Investments | 17.18B | 16.89B | 17.12B | 17.80B | 17.63B |
Goodwill | 17.18B | 16.89B | 17.12B | 17.80B | 17.63B |
Total Other Intangibles | 5.39B | 5.53B | 5.74B | 5.96B | 6.27B |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 2.28B | 2.23B | 2.02B | 2.02B | 1.90B |
Total Assets | 43.48B | 42.09B | 43.10B | 43.46B | 44.01B |
|
|||||
Total Accounts Payable | 2.60B | 2.28B | 2.51B | 2.38B | 1.89B |
Total Accrued Expenses | 5.53B | 5.27B | 5.01B | 4.63B | 4.96B |
Short-term Debt | -- | 500.00M | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 1.77B | 979.00M | 1.98B | 1.02B | 2.20B |
Total Finance Division Other Current Liabilities | 2.35B | 2.36B | 2.34B | 2.37B | 2.43B |
Total Other Current Liabilities | 2.35B | 2.36B | 2.34B | 2.37B | 2.43B |
Total Current Liabilities | 12.25B | 11.39B | 11.84B | 10.41B | 11.47B |
|
|||||
Total Current Liabilities | 12.25B | 11.39B | 11.84B | 10.41B | 11.47B |
Long-Term Debt | 18.16B | 18.50B | 18.70B | 19.67B | 19.10B |
Short-term Debt | -- | 500.00M | -- | -- | -- |
Capital Leases | 343.00M | 324.00M | 338.00M | 345.00M | 371.00M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 4.60B | 4.36B | 4.51B | 4.42B | 4.47B |
Total Liabilities | 35.35B | 34.58B | 35.39B | 34.85B | 35.41B |
|
|||||
Common Stock & APIC | 27.86B | 27.84B | 27.81B | 27.78B | 27.75B |
Retained Earnings | -13.53B | -13.87B | -13.95B | -13.09B | -12.98B |
Treasury Stock & Other | -6.82B | -7.04B | -6.80B | -6.83B | -6.97B |
Total Common Equity | 7.51B | 6.93B | 7.05B | 7.86B | 7.80B |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 7.51B | 6.93B | 7.05B | 7.86B | 7.80B |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | 620.00M | 582.00M | 656.00M | 751.00M | 794.00M |
Total Equity | 8.13B | 7.51B | 7.71B | 8.61B | 8.60B |
|